Israel Englander’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Sell
303,100
-36,100
-11% -$2.91M 0.01% 1478
2026
Q1
$29.4M Sell
339,200
-685,600
-67% -$65.7M 0.01% 1246
2025
Q4
$98.4M Buy
1,024,800
+221,900
+28% +$21.6M 0.04% 442
2025
Q3
$76.5M Sell
802,900
-853,400
-52% -$78.5M 0.03% 583
2025
Q2
$144M Buy
1,656,300
+720,400
+77% +$61.1M 0.07% 258
2025
Q1
$84.1M Buy
935,900
+786,300
+526% +$70.4M 0.04% 443
2024
Q4
$12M Sell
149,600
-197,700
-57% -$17.1M 0.01% 2005
2024
Q3
$31.3M Buy
347,300
+197,200
+131% +$16.6M 0.01% 1165
2024
Q2
$11.8M Buy
150,100
+18,500
+14% +$1.52M 0.01% 1939
2024
Q1
$11.5M Sell
131,600
-17,100
-11% -$1.46M ﹤0.01% 2059
2023
Q4
$12.2M Sell
148,700
-284,400
-66% -$21.7M 0.01% 1992
2023
Q3
$33.9M Buy
433,100
+186,600
+76% +$15.6M 0.02% 992
2023
Q2
$21.7M Sell
246,500
-79,800
-24% -$6.87M 0.01% 1310
2023
Q1
$26.3M Sell
326,300
-253,700
-44% -$20.7M 0.02% 1140
2022
Q4
$45.1M Buy
580,000
+261,400
+82% +$21.2M 0.02% 820
2022
Q3
$25.7M Buy
318,600
+213,900
+204% +$19.2M 0.02% 1114
2022
Q2
$9.4M Sell
104,700
-34,400
-25% -$3.49M 0.01% 2112
2022
Q1
$15.4M Sell
139,100
-89,200
-39% -$9.42M 0.01% 1652
2021
Q4
$23.6M Sell
228,300
-317,200
-58% -$36.7M 0.01% 1293
2021
Q3
$68.4M Buy
545,500
+347,000
+175% +$44.9M 0.04% 482
2021
Q2
$24.6M Buy
198,500
+73,500
+59% +$9.23M 0.02% 1034
2021
Q1
$14.8M Sell
125,000
-73,400
-37% -$8.6M 0.01% 1378
2020
Q4
$23.2M Sell
198,400
-41,200
-17% -$4.54M 0.02% 954
2020
Q3
$24.9K Sell
239,600
-2,400
-1% -$241K 0.03% 655
2020
Q2
$22.2M Sell
242,000
-252,900
-51% -$24.3M 0.03% 671
2020
Q1
$44.6M Buy
494,900
+271,800
+122% +$28.9M 0.1% 180
2019
Q4
$25.3M Buy
223,100
+129,100
+137% +$14.2M 0.03% 699
2019
Q3
$10.2M Buy
94,000
+49,000
+109% +$5.11M 0.02% 1269
2019
Q2
$4.38M Sell
45,000
-60,400
-57% -$5.51M 0.01% 1883
2019
Q1
$9.6M Buy
+105,400
New +$9.43M 0.01% 1291
2018
Q3
Sell
-110,000
Closed -$9.42M 4131
2018
Q2
$9.42M Sell
110,000
-115,000
-51% -$9.61M 0.01% 1354
2018
Q1
$18.1M Buy
225,000
+125,000
+125% +$10.3M 0.02% 934
2017
Q4
$8.07M Buy
100,000
+50,000
+100% +$4M 0.01% 1471
2017
Q3
$3.89M Buy
50,000
+30,000
+150% +$2.49M 0.01% 1809
2017
Q2
$1.77M Buy
+20,000
New +$1.69M ﹤0.01% 2137
2015
Q4
Sell
-50,000
Closed -$3.35M 3633
2015
Q3
$3.35M Buy
+50,000
New +$3.68M 0.01% 1581
2015
Q1
Sell
-210,700
Closed -$15.2M 3896
2014
Q4
$15.2M Buy
210,700
+110,700
+111% +$7.69M 0.03% 741
2014
Q3
$6.2M Buy
+100,000
New +$6.36M 0.02% 1163
2013
Q4
Sell
-24,900
Closed -$1.33M 3632
2013
Q3
$1.33M Sell
24,900
-95,500
-79% -$5.14M ﹤0.01% 1934
2013
Q2
$6.2M Buy
+120,400
New +$5.95M 0.02% 892

Other funds holding MDT

Israel Englander's MDT Position: Q2 2026 in Review

Israel Englander increased its Medtronic (MDT) stake by 94% in Q2 2026, buying an estimated $36M and bringing the position to 918,469 shares worth $71.9M. The position accounts for 0.03% of the portfolio, ranked #687.

Israel Englander first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $560M in Q3 2024. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Israel Englander held 918,469 shares of Medtronic worth $71.9M as of Q2 2026.
  • Israel Englander bought 446,196 Medtronic shares in Q2 2026, an estimated $36M.
  • Medtronic made up 0.03% of Israel Englander's portfolio in Q2 2026, its #687 holding.
  • Israel Englander first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Israel Englander's Medtronic position peaked at $560M in Q3 2024.
  • 2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.